Vorapaxar antiplatelets drug  

SCH-530348 - SCH530348 - SCH 530348 - •Zontivity      

Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultAll cause deathcardiovascular events

acute coronary syndrome  

TRACER, 2011      NCTvorapaxarplacebo (on top standard therapy) Low risk of bias -

cardiovascular prevention  

TRA-2P TIMI 50, 2012        NCTvorapaxarplacebo (on top aspirin)secondary preventionLow risk of bias suggesting -4%-13%
TRA-2P TIMI 50 (no prior stroke sub group), 2012     vorapaxarplacebo (on top aspirin)secondary preventionExploratory suggesting-16%
TRA-2P TIMI 50 (MI subgroup), 2012        NCTvorapaxarplacebo (on top aspirin)secondary preventionExploratory suggesting -7%-19%

post myocardial infarction  

TRA-2P TIMI 50, 2012        NCTvorapaxarplacebo (on top aspirin)secondary preventionLow risk of bias suggesting -4%-13%